Ian Haines

Adj ClinAssProf

1985 …2017
If you made any changes in Pure these will be visible here soon.

Research Output 1985 2017

Filter
Letter
2017

Is there a baby in the bathwater to throw out? Unresolved issues in the dominant prostate-specific antigen screening trial

Haines, I. E., 10 May 2017, In : Journal of Clinical Oncology. 35, 14, p. 1625-1626 2 p.

Research output: Contribution to journalLetterOtherpeer-review

2016

Authors' reply to Kole

Haines, I. E., Ablin, R. J. & Miklos, G. L. G., 2016, In : BMJ: British Medical Journal. 354, 1 p., i3795.

Research output: Contribution to journalLetterOtherpeer-review

2015

FOLFOXIRI and bevacizumab for metastatic colorectal cancer

Haines, I. E., 15 Jan 2015, In : New England Journal of Medicine. 372, 3, p. 290-291 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Prostate cancer screening in Europe

Haines, I., Ablin, R. J. & Miklos, G. L. G., 18 Apr 2015, In : The Lancet. 385, 9977, p. 1506 1 p.

Research output: Contribution to journalLetterOtherpeer-review

2014

Bevacizumab for newly diagnosed glioblastoma

Haines, I. E. & Gabor Miklos, G. L., 1 Jan 2014, In : New England Journal of Medicine. 370, 21, p. 2048-2049 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Response

Haines, I. E. & Miklos, G. L. G., Feb 2014, In : Journal of the National Cancer Institute. 106, 2

Research output: Contribution to journalLetterOtherpeer-review

Response

Haines, I. E. & Miklos, G. L. G., 14 May 2014, In : Journal of the National Cancer Institute. 106, 5, dju081.

Research output: Contribution to journalLetterOtherpeer-review

Strategies to help oncologists deliver high-quality care

Haines, I. E., 20 Jun 2014, In : Journal of Clinical Oncology. 32, 18, p. 1977-1978 2 p.

Research output: Contribution to journalLetterOtherpeer-review

The war on cancer: Time for a new terminology

Haines, I., 2014, In : The Lancet. 383, 9932, p. 1883 1 p.

Research output: Contribution to journalLetterOtherpeer-review

2013

Postoperative radiotherapy for high-risk prostate cancer

Haines, I., Mar 2013, In : The Lancet. 381, 9872, p. 1093 1 p.

Research output: Contribution to journalLetterOtherpeer-review

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: Analysis of trends over time

Haines, I. E., 1 Mar 2013, In : Cancer. 119, 5, p. 1113 1 p.

Research output: Contribution to journalLetterOtherpeer-review

Should the paradigm shift for low-grade follicular non-Hodgkin lymphoma be toward less therapy?

Haines, I. E., 10 May 2013, In : Journal of Clinical Oncology. 31, 14, p. 1797-1798 2 p.

Research output: Contribution to journalLetterOtherpeer-review

The dilemmas of prostate cancer screening

Haines, I. E., 4 Sep 2013, In : Medical Journal of Australia. 199, 9, p. 582-583 2 p.

Research output: Contribution to journalLetterOtherpeer-review

2012

Quality-of-life effects of prostate-specific antigen screening [1]

Haines, I. E., 8 Nov 2012, In : New England Journal of Medicine. 367, 19, p. 1861-1862 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Reply (to Dr Ian Gawler)

Haines, I. E. & Lowenthal, R. M., Apr 2012, In : Internal Medicine Journal. 42, 4, p. 474-475 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Reply (to Dr Ruth Gawler)

Haines, I. E. & Lowenthal, R. M., Apr 2012, In : Internal Medicine Journal. 42, 4, p. 476-478 3 p.

Research output: Contribution to journalLetterOtherpeer-review

2011

Rituximab-containing therapy for chronic lymphocytic leukaemia-Authors reply

Haines, I., Elliott, P. & Stanley, R., 15 Jan 2011, In : The Lancet. 377, 9761, p. 205 1 p.

Research output: Contribution to journalLetterOtherpeer-review

Rituximab maintenance therapy for follicular lymphoma

Haines, I., 2 Apr 2011, In : The Lancet. 377, 9772, p. 1151 1 p.

Research output: Contribution to journalLetterOtherpeer-review

2009

General correspondence: A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia

Haines, I., Elliott, P. & Stanley, R., Apr 2009, In : Internal Medicine Journal. 39, 4, p. 269-271 3 p.

Research output: Contribution to journalLetterOtherpeer-review

In reply

Olver, I. N. & Haines, I. E., 20 Apr 2009, In : Medical Journal of Australia. 190, 8, p. 461 1 p.

Research output: Contribution to journalLetterOtherpeer-review

2008

Dose selection in phase I studies: Why we should always go for the most effective

Haines, I. E., 15 Sep 2008, In : Journal of Clinical Oncology. 26, 21, p. 3650-3652 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Paclitaxel plus bevacizumab for metastatic breast cancer [7]

Haines, I. E. & Miklos, G. L. G., 10 Apr 2008, In : New England Journal of Medicine. 358, 15, p. 1637-1638 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Perspective on "chemotherapy for advanced prostate cancer: 25 Years later": Is it a mirage or an oasis?

Haines, I. E. & Stanley, R. M., 15 Sep 2008, In : Journal of Clinical Oncology. 26, 24, p. 4049-4050 2 p.

Research output: Contribution to journalLetterOtherpeer-review

2007

A positive step forward, but more needed to maximize cost benefits of new-generation cancer therapies.

Haines, I. E., 1 Sep 2007, In : Journal of Clinical Oncology. 25, 25

Research output: Contribution to journalLetterOtherpeer-review

Doubts about whether docetaxel, cisplatin, plus fluorouracil has any benefit in advanced gastric cancer [1]

Haines, I. E., 1 Dec 2007, In : Journal of Clinical Oncology. 25, 34, p. 5528-5529 2 p.

Research output: Contribution to journalLetterOtherpeer-review